Skip to content
Open access · OA via Europe PMC

NRF2 as a guardian of health: from an ancient survival pathway to a modern therapeutic target.

Tenreiro S, Falcão AS, Bender N, Bernatova I, Berry A, Cuadrado A, Eppenberger P, Giona L, Grochot-Przeczek A, Heiss E, Jakubowska M, Long PF, Makhro A, Masoodi M, Morgenstern C

Redox biology · 2026

Abstract

NRF2 (Nuclear Factor Erythroid 2-Related Factor 2) has traditionally been viewed as a master regulator of the antioxidant response. However, emerging evidence redefines NRF2 as a pleiotropic and evolutionarily conserved systems-level integrator of redox, metabolic, proteostatic, and inflammatory homeostasis, i.e., an evolutionarily conserved guardian of health. From its origins as an adaptive response to rising atmospheric oxygen in early metazoans to its role in orchestrating complex cytoprotective networks in humans, NRF2 exemplifies the biological transition from stress resistance to adaptive resilience. Understanding its regulation across species, tissues, life stages and gender offers novel perspectives for combating age-related cellular dysfunction and reframing the dynamic process of redox regulation as a component of adaptive homeostasis in a precision medicine perspective. This review summarizes and integrates essential concepts currently being developed regarding the evolutionary roots of NRF2, its molecular and regulatory complexity, its dualistic role in health and disease, and its potential as a biomarker of resilience and therapeutic target. We highlight NRF2's function as a rheostat rather than a binary stress switch, including the role of hormetic activation through lifestyle and environmental stimuli. By maintaining redox homeostasis and dynamic adaptive stress responses, NRF2 bridges molecular defense mechanisms with strategies for healthspan(definition) extension and preventive medicine from very early life stages until senescence(definition).

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
Europe PMC
DOI
10.1016/j.redox.2026.104217
Canonical
link ↗
Fetched
2026-06-01 MST

Cite this

APA
S, T., AS, F., N, B., I, B., A, B., A, C., P, E., L, G., A, G., E, H., M, J., PF, L., A, M., M, M., C, M., L, S., MC, S., A, S., G, S., &amp; IP., T. (2026). NRF2 as a guardian of health: from an ancient survival pathway to a modern therapeutic target. <em>Redox biology</em>. https://doi.org/10.1016/j.redox.2026.104217
Vancouver
S T, AS F, N B, I B, A B, A C, et al. NRF2 as a guardian of health: from an ancient survival pathway to a modern therapeutic target. Redox biology. 2026. doi:10.1016/j.redox.2026.104217.
BibTeX
@article{tenreiro2026NRFasa, title = {NRF2 as a guardian of health: from an ancient survival pathway to a modern therapeutic target.}, author = {Tenreiro S and Falcão AS and Bender N and Bernatova I and Berry A and Cuadrado A and Eppenberger P and Giona L and Grochot-Przeczek A and Heiss E and Jakubowska M and Long PF and Makhro A and Masoodi M and Morgenstern C and Saso L and Seabra MC and Sznarkowska A and Sykiotis G and Trougakos IP.}, journal = {Redox biology}, year = {2026}, doi = {10.1016/j.redox.2026.104217}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings